Ohio State Surgeons Use New Procedure to Restore Damaged Lungs
Ohio State’s Comprehensive Transplant Center is the first in Ohio and among only a handful nationwide to test a novel method that could potentially double the number of available lungs for transplantation and save more of the 35 million Americans suffering from chronic lung disease. As central Ohio’s only adult transplant center and with one of the country’s largest transplant programs, Ohio State’s Wexner Medical Center is one of 17 institutions across the country certified to evaluate the safety and effectiveness of Ex-Vivo Lung Perfusion (EVLP) through participation in the NOVEL extension clinical trial. “Expanding the number of lifesaving and life-enhancing lung transplants is limited by the number of available donors and the quality of the donated organs. Having the ability to more adequately evaluate potential donor organs and to even repair or resuscitate them is a game changer for lung transplantation,” said Dr. Bryan Whitson, a cardiothoracic surgeon and director of the lung transplant program at Ohio State’s Wexner Medical Center. This story resulted from pitching efforts by OSU Wexner Medical Center Public Affairs and Media Relations.